Some evidences35 indicate that IFN-γ+IL-17+ cells are potentially pathogenic Th17 cells in multiple sclerosis patients and reduction of IFN-γ-producing Th17 cell numbers is a potential strategy for the treatment of autoimmune disease. Here, IL17A is linked to multiple sclerosis.